
sabboko
635 posts

sabboko
@sabboko
Tweets in Swedish and English, mostly about stocks and economy. No recommendations. Do your own research.





















My story: wapo.st/4rBNSWR

1/🚨WOW! @WaveLifeSci has presented positive clinical data from its Phase 1 INLIGHT Trial of $WVE-007 (INHBE) for Obesity demonstrating that a single 240 mg dose of WVE-007 led to an improvement in body composition with fat loss similar to GLP-1 drugs - such as $NVO Semaglutide and $LLY tirzepatide at 3 months without any muscle loss! WVE-007 is an investigational INHBE GalNAc-siRNA program which uses Wave’s proprietary SpiNA platform and is designed to treat Obesity. Today’s clinical data showed that a single 240 mg dose of WVE-007 led to an improvement in body composition characterized by reductions in total and visceral fat mass at three months and to an increase in lean mass. WVE-007 also demonstrated a favorable safety profile as well as durable reductions in serum Activin E that support potential once or twice-yearly dosing. This is a super important milestone in the Obesity and Weight Loss field! $XBI









